Role of Serum Procalcitonin in Diagnosis and Management of Biliary Tract Infection

Role of Serum Procalcitonin in Diagnosis and Management of Biliary Tract Infection - Role of Serum Procalcitonin in Diagnosis and Management of Biliary Tract Infection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010202

Enrollment

500

Registered

2013-03-11

Start date

2013-03-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary tract infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Study 1. Patients with acute cholangitis, acute cholecystitis, or liver abscess, who started antibiotic therapy at the time of admission. Study 2. Patients with acute cholangitis, acute cholecystitis, or liver abscess, who started antibiotic therapy at the time of admission and who received endoscopic or percutaneous drainage. Patients with written informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with other active concomitant infections. 2) Patients considered ineligible for this study.

Design outcomes

Primary

Measure	Time frame
Study 1. To determine the cut-off value of serum procalcitonin in the diagnosis and severity assessment of biliary tract infection. Study 2. To examine the correlation between time to defervescence and serum procalcitonin value in patients with biliary tract infection.	—

Countries

Japan

Contacts

Public ContactHirofumi Kogure

Faculty of Medicine, The University of Tokyo Department of Gastroenterology

kogureh-tky@umin.ac.jp03-3815-5411

Outcome results